Get the Stockscreener App
3.84
2.40%
0.09
Pre-market:
3.95
0.11
+2.86%
Health Catalyst Inc stock is traded at $3.84, with a volume of 465.55K.
It is up +2.40% in the last 24 hours and down -13.71% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$3.75
Open:
$3.72
24h Volume:
465.55K
Relative Volume:
0.58
Market Cap:
$269.61M
Revenue:
$299.48M
Net Income/Loss:
$-86.45M
P/E Ratio:
-2.56
EPS:
-1.5
Net Cash Flow:
$-17.32M
1W Performance:
+0.26%
1M Performance:
-13.71%
6M Performance:
-55.61%
1Y Performance:
-31.73%
1-Day Range:
$3.61
$3.885
1-Week Range:
$3.56
$4.31
52-Week Range:
$3.56
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
3.84 | 269.61M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
215.95 | 36.39B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
53.21 | 9.87B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
40.45 | 7.46B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
84.52 | 7.21B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.45 | 6.30B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025 - The Manila Times
Healthcare Analytics Leader Health Catalyst Sets Q1 2025 Earnings Release Date - Stock Titan
Health Catalyst stock hits 52-week low at $3.56 amid market challenges By Investing.com - Investing.com South Africa
Health Catalyst stock hits 52-week low at $3.56 amid market challenges - Investing.com India
KeyBanc Adjusts Price Target for Health Catalyst (HCAT) Ahead of Q1 Earnings | HCAT Stock News - GuruFocus
Cantor Fitzgerald maintains overweight rating on Health Catalyst stock By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains overweight rating on Health Catalyst stock - Investing.com
Healthcare Data Analytics Market Is Booming Worldwide 2025-2032 | Health Catalyst, Oracle, Optum, SAS - openPR.com
HIMSSCast: "How do we grow again?" - Healthcare Finance News
Health Catalyst launches data and analytics solution for healthcare organisations - Yahoo Finance
Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025 - Yahoo Finance
Health Catalyst Releases Data and Analytics Solution Designed fo - GuruFocus
Health Catalyst Releases Data and Analytics Solution Designed for Community, Regional, and Specialty Health Systems: Health Catalyst Ignite Spark™ - PR Newswire
This PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Forecasting The Future: 10 Analyst Projections For Health Catalyst - Benzinga
Evercore ISI cuts Health Catalyst stock rating to In Line By Investing.com - Investing.com India
Evercore ISI cuts Health Catalyst stock rating to In Line - Investing.com
Health Catalyst COO Daniel LeSueur sells shares worth $21,604 By Investing.com - Investing.com South Africa
Health Catalyst COO Daniel LeSueur sells shares worth $21,604 - Investing.com Australia
Health Catalyst stock hits 52-week low at $3.75 amid market challenges - Investing.com India
Health Catalyst stock hits 52-week low at $3.75 amid market challenges By Investing.com - Investing.com South Africa
Institutional investors may adopt severe steps after Health Catalyst, Inc.'s (NASDAQ:HCAT) latest 10.0% drop adds to a year losses - simplywall.st
Personalized healthcare: Resolving the payer-provider conflict for better patient outcomes - Modern Healthcare
5 leading hospital chargemaster software products - TechTarget
Health Catalyst: Share Price Continues To Dismiss Positive Earnings And Improved Outlook - Seeking Alpha
Is the Options Market Predicting a Spike in Health Catalyst (HCAT) Stock? - TradingView
Healthcare Predictive Analytics Market Set to Witness - openPR
Health Catalyst stock rating reiterated at William Blair - Investing.com
Health Catalyst stock rating reiterated at William Blair By Investing.com - Investing.com Australia
Predictive Disease Analytics Market Top Players- SAS; - openPR
Health Catalyst repurchases $5M worth of shares - MSN
Health Catalyst buys back $5 million in stock By Investing.com - Investing.com Australia
Health Catalyst Expands Buyback With $5 Mln Share Repurchase - Nasdaq
Health Catalyst to buy back shares worth about $5 mln -March 11, 2025 at 10:37 am EDT - Marketscreener.com
Health Catalyst Repurchases $5 Million in Common Stock -March 11, 2025 at 10:20 am EDT - Marketscreener.com
Health Catalyst Announces ~$5 Million Stock Repurchase - Quantisnow
Health Catalyst buys back $5 million in stock - Investing.com
Health Catalyst COO Daniel LeSueur sells $76,331 in stock By Investing.com - Investing.com Australia
Health Catalyst general counsel Landry Benjamin sells $62,860 in stock By Investing.com - Investing.com Canada
Health Catalyst general counsel Landry sells shares worth $62,860 - Investing.com
Health Catalyst general counsel Landry sells shares worth $62,860 By Investing.com - Investing.com Canada
Health Catalyst general counsel Landry Benjamin sells $62,860 in stock - Investing.com
Health Catalyst COO Daniel LeSueur sells $76,331 in stock - Investing.com India
Take Care Before Jumping Onto Health Catalyst, Inc. (NASDAQ:HCAT) Even Though It's 27% Cheaper - Simply Wall St
Stephens Issues Pessimistic Forecast for Health Catalyst (NASDAQ:HCAT) Stock Price - Defense World
10 Analysts Have This To Say About Health Catalyst - Benzinga
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
0.80%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):